Your browser doesn't support javascript.
loading
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
Piñana, José Luis; Heras, Inmaculada; Aiello, Tommaso Francesco; García-Cadenas, Irene; Vazquez, Lourdes; Lopez-Jimenez, Javier; Chorão, Pedro; Aroca, Cristina; García-Vidal, Carolina; Arroyo, Ignacio; Soler-Espejo, Eva; López-Corral, Lucia; Avendaño-Pita, Alejandro; Arrufat, Anna; Garcia-Gutierrez, Valentín; Arellano, Elena; Hernández-Medina, Lorena; González-Santillana, Clara; Morell, Julia; Hernández-Rivas, José Ángel; Rodriguez-Galvez, Paula; Mico-Cerdá, Mireia; Guerreiro, Manuel; Campos, Diana; Navarro, David; Cedillo, Ángel; Martino, Rodrigo; Solano, Carlos.
Afiliação
  • Piñana JL; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.
  • Heras I; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.
  • Aiello TF; Hematology Division, Hospital Morales Meseguer, 30100 Murcia, Spain.
  • García-Cadenas I; Infectious Disease Division, Hospital Clinic, 08193 Barcelona, Spain.
  • Vazquez L; Hematology Division, Hospital de la Santa Creu i Sant Pau, 08193 Barcelona, Spain.
  • Lopez-Jimenez J; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Chorão P; Hematology Division, Hospital Ramon y Cajal, 28029 Madrid, Spain.
  • Aroca C; Hematology Division, Hospital Universitario y Politécnico La Fe, 46017 Valencia, Spain.
  • García-Vidal C; Hematology Division, Hospital Morales Meseguer, 30100 Murcia, Spain.
  • Arroyo I; Infectious Disease Division, Hospital Clinic, 08193 Barcelona, Spain.
  • Soler-Espejo E; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.
  • López-Corral L; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.
  • Avendaño-Pita A; Hematology Division, Hospital Morales Meseguer, 30100 Murcia, Spain.
  • Arrufat A; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Garcia-Gutierrez V; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Arellano E; Hematology Division, Hospital de la Santa Creu i Sant Pau, 08193 Barcelona, Spain.
  • Hernández-Medina L; Hematology Division, Hospital Ramon y Cajal, 28029 Madrid, Spain.
  • González-Santillana C; Hematology Division, Hospital Universitario Virgen Macarena, 41092 Sevilla, Spain.
  • Morell J; Hematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Hernández-Rivas JÁ; Hematology Division, Hospital de Fuenlabrada, 28029 Madrid, Spain.
  • Rodriguez-Galvez P; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.
  • Mico-Cerdá M; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.
  • Guerreiro M; Hematology Division, Hospital Universitario Infanta Leonor, 28029 Madrid, Spain.
  • Campos D; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.
  • Navarro D; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.
  • Cedillo Á; Hematology Department, Hospital Clínico Universitario, 46017 Valencia, Spain.
  • Martino R; INCLIVA, Biomedical Research Institute, 46017 Valencia, Spain.
  • Solano C; Hematology Division, Hospital Universitario y Politécnico La Fe, 46017 Valencia, Spain.
Viruses ; 15(10)2023 10 08.
Article em En | MEDLINE | ID: mdl-37896843

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article